机译:紫杉醇联合卡铂,表阿霉素,吉西他滨或长春瑞滨在乳腺癌细胞系和肿瘤样品中的药物相互作用和细胞毒性作用
Division of Hematology-Oncology Department of Medicine University of California Los Angeles School of Medicine;
Department of Obstetrics and Gynecology Klinikum Grosshadern Ludwig Maximillians Universität München;
Division of Hematology-Oncology Department of Medicine University of California Los Angeles School of Medicine;
Division of Hematology-Oncology Department of Medicine University of California Los Angeles School of Medicine;
Department of Obstetrics and Gynecology Klinikum Grosshadern Ludwig Maximillians Universität München;
Department of Obstetrics and Gynecology Klinikum Grosshadern Ludwig Maximillians Universität München;
Department of Obstetrics and Gynecology Klinikum Grosshadern Ludwig Maximillians Universität München;
Department of Obstetrics and Gynecology Klinikum Grosshadern Ludwig Maximillians Universität München;
Department of Obstetrics and Gynecology Klinikum Grosshadern Ludwig Maximillians Universität München;
Division of Hematology-Oncology Department of Medicine University of California Los Angeles School of Medicine;
breast cancer; carboplatin; epirubicin; gemcitabine; in vitro; paclitaxel; vinorelbine;
机译:紫杉醇联合卡铂,表柔比星,吉西他滨或长春瑞滨在乳腺癌细胞系和肿瘤样品中的药物相互作用和细胞毒性作用。
机译:新的反式2,4-二芳基-r-3-甲基-1,2,3,4-四氢喹啉的细胞毒性作用及其与抗肿瘤药吉西他滨和紫杉醇的相互作用对人乳腺癌细胞的影响。
机译:1-3例阳性淋巴结的乳腺癌患者的辅助治疗:长春瑞滨加表柔比星;长春瑞滨加表柔比星序贯,随后紫杉醇;表柔比星加环磷酰胺;表柔比星加环磷酰胺序贯
机译:富勒烯醇C_(OH)(OH)(24)对人乳腺癌细胞系抗肿瘤诱导的细胞毒性的影响
机译:吉西他滨和紫杉醇吸收的增强和转移性癌细胞的保留:一种小型靶向组合递送方法,消除血液和淋巴中的乳腺癌
机译:晚期非小细胞肺癌的生活质量评估:长春瑞滨加吉西他滨加多西他赛与紫杉醇加卡铂方案的比较:一项随机试验:日本跨国试验组织LC00-03(BRI LC03-01)
机译:Neoadjuvant-Acduvant组合治疗的长期随访IIIA期非小型细胞肺癌:Neoadjuvant Carboplatin / Vinorelbine和Carboplatin / PAClitaxel方案的结果联合了根据体外化学化学测试的选择性佐剂化疗